The Leadership Team
Dr. Chris Yu
Co-Founder / Chief Executive Officer
Dr. Chris Yu attended medical school before changing his studies to Physics and earning his Ph.D. from Pennsylvania State University. He is a successful Fortune 500 business executive, innovative engineer, and pioneering inventor.
Clay Johnson joined Anpac Bio-Medical Science Co., Ltd. as a consultant in March 2019 and in that role is providing general counsel services to the company. Clay is a leading international corporate lawyer with extensive experience in the U.S., China and the rest of Asia.
Shaun Gong has worked as consultant for Anpac Bio in both China and North America since 2016, and was officially appointed to be Deputy President of the company’s North American branch in May 2019.
U.S. Technical Team
Dr. Lee P. Shulman
Technical Board Consultant
Alfred Lui, M. D., FCAP
CLIA Laboratory Director
Dr. Herbert Yu
Co-Founder/Chief Science Officer
Sharon Vorse-Yu , M. S.
VP of Technical Operations
Our Worldwide Team
Anpac Bio employs nearly 70 creative and innovative scientists, researchers, engineers, and business professionals worldwide. Educated at internationally-acclaimed, universities and educational institutions (such as Yale University); and recruited from Fortune 500, NYSE- and NASDAQ-listed corporations (including General Electric, Bayer, Roche, etc.); Anpac employees are recognized leaders in the medical device industry and technology industries.
Collectively, Anpac Bio’s employees are the inventors of over 500 patent applications. The company’s multi-disciplinary, collaborative approach results in a strong track record of successful innovation, leading to laboratory trials, pilot plant development, full-scale manufacturing, and market growth.
Anpac Bio-Medical’s scientists have been invited to share the company’s breakthrough CDA research results at respected international health and science events such as the Nobel Prize Laureate Summit on Biomedical Science, the American Society of Clinical Oncology, and the international ASCO Breast Cancer Symposium.
Anpac Bio is mission-focused on developing tools for early disease detection. As part of that mission, the company promotes a healthy corporate culture of creativity, teamwork, balance, and commitment to excellence, family, and social responsibility.
The company’s unique, cross-disciplinary approach combines medicine, biochemistry, and engineering—to achieve vastly superior early disease screening and detection technology.